相似文献
1
Expanding Armamentarium in Heart Disease.
Med J Armed Forces India. 2008 Apr;64(2):102-3. doi: 10.1016/S0377-1237(08)80046-9. Epub 2011 Jul 21.
2
Major adverse cardiovascular events in patients undergoing percutaneous coronary intervention or coronary artery bypass graft with underlying chronic kidney disease.
J Pak Med Assoc. 2020 Nov;70(11):1901-1907. doi: 10.5455/JPMA.22790.
3
Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.
Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):997-1001. doi: 10.1093/icvts/ivu288. Epub 2014 Sep 2.
4
Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis.
Ren Fail. 2014 Sep;36(8):1177-86. doi: 10.3109/0886022X.2014.934178. Epub 2014 Jul 2.
5
Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003459.
6
Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study.
Scand Cardiovasc J. 2024 Dec;58(1):2347297. doi: 10.1080/14017431.2024.2347297. Epub 2024 May 2.
7
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9. doi: 10.1016/j.jtcvs.2004.12.049.
8
Narrowing the gap: early and intermediate outcomes after percutaneous coronary intervention and coronary artery bypass graft procedures in California, 1997 to 2006.
J Thorac Cardiovasc Surg. 2009 Nov;138(5):1100-7. doi: 10.1016/j.jtcvs.2009.03.069.
9
Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
Eur J Cardiothorac Surg. 2015 Feb;47(2):316-21; discussion 321. doi: 10.1093/ejcts/ezu131. Epub 2014 Mar 23.
10
A comparative study of bypass versus percutaneous intervention for left main disease.
Tunis Med. 2019 Apr;97(4):533-540.
本文引用的文献
1
Coronary Artery Revascularisation : Past, Present and Future.
Med J Armed Forces India. 2008 Apr;64(2):154-7. doi: 10.1016/S0377-1237(08)80063-9. Epub 2011 Jul 21.
2
Percutaneous Closure of Perimembranous Ventricular Septal Defect with Amplatzer Device.
Med J Armed Forces India. 2008 Apr;64(2):131-5. doi: 10.1016/S0377-1237(08)80055-X. Epub 2011 Jul 21.
3
Long-term outcomes of coronary-artery bypass grafting versus stent implantation.
N Engl J Med. 2005 May 26;352(21):2174-83. doi: 10.1056/NEJMoa040316.
4
Immunomodulation of atherosclerosis: implications for vaccine development.
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):18-28. doi: 10.1161/01.ATV.0000149142.42590.a2. Epub 2004 Oct 28.
5
Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
Circulation. 2004 Jun 1;109(21):2487-91. doi: 10.1161/01.CIR.0000128595.79378.FA.
6
Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia.
Circulation. 2000 Aug 29;102(9):965-74. doi: 10.1161/01.cir.102.9.965.
Zotero 插件